MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Inpatient Multimodal Care Improves Parkinsonian Symptoms Regardless Of Race Or Ethnicity

N. Elayan, L. Rubin, M. Mccrossin, A. Di Rocco, M. Ghilardi (New York, USA)

Meeting: 2025 International Congress

Keywords: Depression, Parkinson’s, Rehabilitation

Category: Parkinson’s Disease: Pharmacology and Medical Management

Objective: To verify demographic characteristics of patients with Parkinson’s disease (PD) completing a two-week inpatient multimodal intensive neurorehabilitation and care (iMINC) program and whether iMINC had similar effects across ethnicities and races.

Background: PD is the fastest growing neurodegenerative disease with similar incidence across races and ethnicities. However, the best predictors for optimal care are high socio-economic level, marital status, urban living, and white patients. One of the most complete care models has been established in Europe more than a decade ago in specialized centers. It is based on four-week inpatient multimodal intense programs that result in improvements for most motor and non-motor symptoms at all PD stages. It has been recently reproduced in the US at Northwell Health Glen Cove Hospital with a two-week program of intense rehabilitation, neuropsychology, dietary, social worker care, art therapy, and caregiver support.

Method: In this retrospective study, we reviewed records of patients that completed iMINC and compared pre- and post-iMINC outcome measures (UPDRSIII, Beck Depression Inventory [BDI], PD sleep scale, and PDQ39).

Results: We found that 336 patients with PD included 14 Hispanic (4.2%), 24 Asian (7.1%), 17 African-American (5.1%), and 279 Caucasian (83%) subjects underwent iMINC for a 14-day median. At baseline, Hispanic and Asian groups did not differ from the other groups in terms of age, stage, and motor UPDRS scores, although they had on average worse scores of Beck Depression Inventory, PD sleep scale, and PDQ39, suggesting that non motor symptoms may be more severe in these two groups. After iMINC, all outcome measures significant improved in all patient groups, without differences between groups (all tests p>0.1).

Conclusion: Participation to iMINC program by non-Caucasian patients with PD is very limited, especially considering New York City demographic composition. Nevertheless, iMINC can provide significant benefit to patients regardless of race or ethnicity, improving both motor and non-motor PD symptoms. Future work is needed to confirm these results in larger populations and to address the scarcity of non Caucasian patients possibly with community-based programs.

To cite this abstract in AMA style:

N. Elayan, L. Rubin, M. Mccrossin, A. Di Rocco, M. Ghilardi. Inpatient Multimodal Care Improves Parkinsonian Symptoms Regardless Of Race Or Ethnicity [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/inpatient-multimodal-care-improves-parkinsonian-symptoms-regardless-of-race-or-ethnicity/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/inpatient-multimodal-care-improves-parkinsonian-symptoms-regardless-of-race-or-ethnicity/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley